BEIJING ENT Restructures Board: New Governance, Compliance and Sustainability Committees Established

Bulletin Express
04/28

BEIJING ENT (Beijing Enterprises Holdings Limited) announced a comprehensive overhaul of its board committee structure, effective 28 April 2026, aimed at strengthening corporate governance, strategic oversight and ESG management.

Key changes and additions:

1. Nomination Committee upgraded • Renamed “Nomination and Governance Committee” to reflect an expanded mandate that now covers board effectiveness, director independence and overall governance framework. • Composition unchanged: Executive Director Yang Zhichang (chairman) and Independent Non-Executive Directors (INEDs) Dr. Yu Sun Say and Chan Man Ki Maggie.

2. Investment Committee broadened • Renamed “Strategy and Investment Committee,” adding responsibility for medium- to long-term strategic planning. • Membership expanded to five directors. Executive Director Xiong Bin becomes chairman, joined by Executive Directors Xu Tong and Tung Woon Cheung Eric, and INEDs Lam Hoi Ham and Chan Man Ki Maggie. Yang Zhichang steps down from this committee.

3. New Rule of Law and Compliance Committee • Five-member body led by Executive Director Xiong Bin. Other members: Executive Directors Geng Chao and Tung Woon Cheung Eric, Non-Executive Director (NED) Su Junjie and INED Chan Man Ki Maggie. • Charged with guiding and monitoring legal compliance and risk prevention across the group.

4. New Sustainability Committee • Chaired by Executive Director Xiong Bin; members include Executive Director Tung Woon Cheung Eric, NEDs Yu Xijian and Su Junjie, and INED Wu Jiesi. • Tasked with steering ESG strategy, overseeing sustainability risk management and ensuring alignment with Hong Kong Stock Exchange ESG disclosure requirements.

5. Remuneration Committee adjustment • Executive Director Xiong Bin joins as a member, replacing Yang Zhichang. • Committee now comprises Xiong Bin (Executive Director) and INEDs Wu Jiesi (chairman) and Lam Hoi Ham, maintaining an INED majority in line with Listing Rule 3.25.

Following these updates, the board still consists of 11 directors: five executive, two non-executive and four independent non-executive members.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10